Seroprevalence of herpes simplex virus type 2 and characteristics associated with undiagnosed infection: New York City, 2004

Sexually Transmitted Diseases

Volumn 35, Issue 6, 2008, Pages 599-606

  Schillinger, Julia A ^a,b   McKinney, Christy M ^c   Garg, Renu ^a   Gwynn, R Charon ^d   White, Kellee ^e   Lee, Francis ^f   Blank, Susan ^a,b   Thorpe, Lorna ^a   Frieden, Thomas ^a  

^a NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c University of Texas at Houston   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e NEW YORK ACADEMY OF MEDICINE   (United States)

^f EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GROUPS BY AGE; HEALTH SURVEY; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HISPANIC; HUMAN; INFECTION RISK; MALE; MALE HOMOSEXUAL; NEGRO; POPULATION RESEARCH; SCREENING TEST; SEROPREVALENCE; SEXUAL BEHAVIOR; SEXUAL HEALTH; UNITED STATES; VIRUS TRANSMISSION; BLOOD; EPIDEMIOLOGY; GENITAL HERPES; IMMUNOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; RISK FACTOR;

VIRUS ANTIBODY;

ADULT; ANTIBODIES, VIRAL; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HUMANS; MALE; MIDDLE AGED; NEW YORK CITY; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES;

EID: 48049113050     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3181666fb1     Document Type: Article

References (41)

1. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: A meta-analysis. J Infect Dis 2002; 185:45-52.
2. Freeman EE, Weiss HA, Glynn JR, et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: Systematic review and meta-analysis of longitudinal studies. AIDS 2006; 20:73- 83.
3. Strick LB, Wald A, Celum C. Management of herpes simplex virus type 2 infection in HIV type 1-infected persons. Clin Infect Dis 2006; 43:347-356.
4. Nagot N, Ouedraogo A, Foulongne V, et al. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med 2007; 356:790-799.
5. Xu F, Sternberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 2006; 296:964-973.
6. Armstrong GL, Schillinger J, Markowitz L, et al. Incidence of herpes simplex virus type 2 infection in the United States. Am J Epidemiol 2001; 153:912-920.
7. Gottlieb SL, Douglas JM Jr, Schmid DS, et al. Seroprevalence and correlates of herpes simplex virus type 2 infection in five sexually transmitted-disease clinics. J Infect Dis 2002; 186:1381-1389.
8. Singh AE, Romanowski B, Wong T, et al. Herpes simplex virus seroprevalence and risk factors in 2 Canadian sexually transmitted disease clinics. Sex Transm Dis 2005; 32:95-100.
9. Leone P, Fleming DT, Gilsenan AW, et al. Seroprevalence of herpes simplex virus-2 in suburban primary care offices in the United States. Sex Transm Dis 2004; 31:311-316.
10. Renzi C, Douglas JM Jr, Foster M, et al. Herpes simplex virus type 2 infection as a risk factor for human immunodeficiency virus acquisition in men who have sex with men. J Infect Dis 2003; 187:19-25.
11. Siegel D, Golden E, Washington AE, et al. Prevalence and correlates of herpes simplex infections. The population-based AIDS in Multiethnic Neighborhoods Study. JAMA 1992; 268:1702-1708.
12. Weiss HA, Thomas SL, Munabi SK, et al. Male circumcision and risk of syphilis, chancroid, and genital herpes: A systematic review and meta-analysis. Sex Transm Infect 2006; 82:101-109.
13. Cook LS, Koutsky LA, Holmes KK. Circumcision and sexually transmitted diseases. Am J Public Health 1994; 84:197-201.
14. Wald A, Koutsky L, Ashley RL, et al. Genital herpes in a primary care clinic. Demographic and sexual correlates of herpes simplex type 2 infections. Sex Transm Dis 1997; 24:149-155.
15. Cherpes TL, Meyn LA, Krohn MA, et al. Risk factors for infection with herpes simplex virus type 2: Role of smoking, douching, uncircumcised males, and vaginal flora. Sex Transm Dis 2003; 30:405-410.
16. Fife KH, Bernstein DI, Tu W, et al. Predictors of herpes simplex virus type 2 antibody positivity among persons with no history of genital herpes. Sex Transm Dis 2004; 31:676-681.
17. Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997; 337:1105-1111.
18. Langenberg A, Benedetti J, Jenkins J, et al. Development of clinically recognizable genital lesions among women previously identified as having "asymptomatic" herpes simplex virus type 2 infection. Ann Intern Med 1989; 110:882-887.
19. Wald A, Langenberg AG, Krantz E, et al. The relationship between condom use and herpes simplex virus acquisition. Ann Intern Med 2005; 143:707-713.
20. Corey L, Wald A, Patel R, et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004; 350:11-20.
21. US Centers for Disease Control and Prevention National Health and Nutrition Examination Survey Data. Available at: http://www.cdc. gov/nchs/about/major/nhanes/nhanes2003-2004/nhanes03-04.htm. Accessed October 16, 2007.
22. Thorpe LE, Gwynn RC, Mandel-Ricci J, et al. Study design and participation rates of the New York City Health and Nutrition Examination Survey, 2004. Prev Chronic Dis 2006; 3:A94.
23. Williams ML, Freeman RC, Bowen AM, et al. A comparison of the reliability of self-reported drug use and sexual behaviors using computer-assisted versus face-to-face interviewing. AIDS Educ Prev 2000; 12:199-213.
24. Metzger DS, Koblin B, Turner C, et al. Randomized controlled trial of audio computer-assisted self-interviewing: Utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team. Am J Epidemiol 2000; 152:99-106.
25. Lee FK, Coleman RM, Pereira L, et al. Detection of herpes simplex virus type 2-specific antibody with glycoprotein G. J Clin Microbiol 1985; 22:641-644.
26. Lee FK, Pereira L, Griffin C, et al. A novel glycoprotein for detection of herpes simplex virus type 1-specific antibodies. J Virol Methods 1986; 14:111-118.
27. Klein RJ, Schoenborn CA. Age adjustment using the 2000 projected U.S. population. Healthy People 2010 Stat Notes 2001; 1-10.
28. Chartbook on Trends in the Health of Americans. Hyattsville, Maryland: National Center for Health Statistics, 2005.
29. Fleming DT, Leone P, Esposito D, et al. Herpes virus type 2 infection and genital symptoms in primary care patients. Sex Transm Dis 2006; 33:416-421.
30. Marrazzo JM, Stine K, Wald A. Prevalence and risk factors for infection with herpes simplex virus type-1 and -2 among lesbians. Sex Transm Dis 2003; 30:890-895.
31. U.S. Census Bureau Census 2000, Summary File 1, Am Fact Finder. Available at: http://factfinder.census.gov. Accessed April 18, 2006.
32. Youm Y, Laumann EO. Social network effects on the transmission of sexually transmitted diseases. Sex Transm Dis 2002; 29:689-697.
33. Langenberg AG, Corey L, Ashley RL, et al. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med 1999; 341:1432-1438.
34. Koutsky LA, Ashley RL, Holmes KK, et al. The frequency of unrecognized type 2 herpes simplex virus infection among women. Implications for the control of genital herpes. Sex Transm Dis 1990; 17:90-94.
35. Nguyen TQ, Gwynn RC, Kellerman SE, et al. Population prevalence of reported and unreported HIV and related behaviors among the New York City household adult population, 2004. AIDS 2008; 22:281-287.
36. Krantz I, Lowhagen GB, Ahlberg BM, et al. Ethics of screening for asymptomatic herpes virus type 2 infection. BMJ 2004; 329:618-621.
37. Centers for Disease Control and Prevention. Sexually Transmitted Disease Guidelines, 2006. MMWR Morb Mortal Wkly Rep 2006; 55.
38. Guerry SL, Bauer HM, Klausner JD, et al. Recommendations for the selective use of herpes simplex virus type 2 serological tests. Clin Infect Dis 2005; 40:38-45.
39. New York City Department of Health and Mental Hygiene. HIV Epidemiology Program 2nd Semiannual Report. New York, 2006.
40. Barton S, Celum C, Schacker T. The role of anti-HSV therapeutics in the HIV-infected host and in controlling the HIV epidemic (consensus article - IHMF management recommendations). Herpes 2005; 12:15-22.
41. Fowler ME. Recognizing the phenomenon of readiness: Concept analysis and case study. J Assoc Nurses AIDS Care 1998; 9:72-76.